Hydrogel-Based Drug Delivery System Market 2028 By Source, Route of Administration, and Geography | The Insight Partners

report image

Hydrogel-Based Drug Delivery System Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Source (Natural, Synthetic, and Hybrid); Route of Administration (Subcutaneous, Ocular, Oral Cavity, Topical, and Other), and Geography

Report Code: TIPRE00024309 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

MARKET OVERVIEW

Hydrogels are 3D networks of water-soluble polymers that are cross-linked. Hydrogels are produced from almost any water-soluble polymer, and these can have a range of chemical compositions and bulk physical characteristics. Moreover, hydrogels can be made in multiple physical shapes, like slabs, microparticles, nanoparticles, coatings, and films. Therefore, hydrogels are widely used in clinical practice and experimental medicine for several applications, including tissue engineering and regenerative medicine, diagnostics, cellular immobilization, biomolecule or cell separation, and barrier materials to govern biological adhesions. Traditional drug delivery methods are hindered by concerns such as systemic toxicity and repetitive dosage. Hydrogels provide convenient drug delivery carriers, ensuring that these disadvantages are reduced while the drug's therapeutic benefits are enhanced. Hydrogels have emerged as highly efficient drug delivery systems due to delicately adjustable physical characteristics that provide controlled drug release features and the benefits of labile drug protection from degradation.

MARKET SCOPE

The "Global Hydrogel-Based Drug Delivery System Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Hydrogel-based drug delivery system market with detailed market segmentation by source, route of administration, and geography. The report provides key statistics on the market status of the leading Hydrogel-based drug delivery system market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on source, the global Hydrogel-based drug delivery system market is segmented into natural, synthetic, hybrid.
  •  On the basis of route of administration, the market is segmented into subcutaneous, ocular, oral cavity, topical, other.

MARKET DYNAMICS
Drivers:

  •  Increasing investment and funding by leading pharma companies in R&D activities in search of a new drug, delivery systems, and diagnostic.
  •  Rise in the demand for controlled release drug delivery system.
  •  Growth in the R&D efforts related to drug delivery systems.

Restraints:

  •  The complexity to produce hydrogel is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Hydrogel-based drug delivery system market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Hydrogel-based drug delivery system market in these regions.

IMPACT OF COVID-19ON HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Hydrogel-based drug delivery system market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Hydrogel-based drug delivery system market are anticipated to lucrative growth opportunities in the future with the rising demand for Hydrogel-based drug delivery system in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Hydrogel-based drug delivery system market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  GlaxoSmithKline
  •  Alliance Pharmaceuticals Limited
  •  Oraldent Ltd.
  •  Ashland
  •  Johnson & Johnson
  •  Pfizer, Inc.
  •  Gilead Sciences
  •  Teva Pharmaceutical Industries Ltd.
  •  Valeant Pharmaceuticals International, Inc.
  •  Ferring B.V.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

The List of Companies

1. GlaxoSmithKline
2. Alliance Pharmaceuticals Limited
3. Oraldent Ltd.
4. Ashland
5. Johnson & Johnson
6. Pfizer, Inc.
7. Gilead Sciences
8. Teva Pharmaceutical Industries Ltd.
9. Valeant Pharmaceuticals International, Inc.
10. Ferring B.V.
11. Endo International plc
12. Akorn, Incorporated
13. Tolmar Pharmaceuticals, Inc.
14. GALDERMA
15. Blairex Laboratories, Inc.
16. Bausch and Lomb
17. Medtronic
18. Ocular Therapeutix, Inc.
TIPRE00024309
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount